Results 151 to 160 of about 44,772 (320)

The efficacy of combination of ondansetron and aprepitant on preventing the radiotherapy-induced nausea and vomiting

Journal of Research in Medical Sciences, 2015
Background: Depending on the site of irradiation, about 40-80% of patients undergoing radiotherapy (RT) will experience nausea and/or vomiting. The current study aimed to investigate the efficacy of ondansetronas as a single agent and with a combination ...
Hamid Emami, Simin Hematti, Seyed Masoud Saeidian, Awat Feizi, Shahin Taheri, Pourya Adeli, Golshan Mahmoudi   +6 more
doaj  

The therapeutic targets and signaling mechanisms of ondansetron in the treatment of critical illness in the ICU

Frontiers in Pharmacology
BackgroundThere is accumulating evidence regarding the benefits of the 5-HT3 receptor antagonist ondansetron for the treatment of critical illness due to its potential anti-inflammatory effect.
Lili Tao, Lili Tao, Zhenhui Zhang, Chuang Li, Minxuan Huang, Ping Chang   +5 more
doaj   +1 more source

Ondansetron prevents refractory and severe methotrexate-induced nausea in rheumatoid arthritis [PDF]

, 1998
Rodŕiguez Blanco, Miguel Á. González‐Gay, Carlos García‐Porrúa, D Ibáñez, Ma José García-Pais, A Sánchez-Andrade, Manuel Vázquez‐Caruncho   +6 more
openalex   +1 more source

The Comparison Effect of Preoperative Ondansetron and Metoclopramide in Reducing Nausea and Vomitting after Loparoscopic Cholecystectomy

Journal of Ardabil University of Medical Sciences, 2013
Background & Objectives: Postoperative nausea and vomiting (PONV) is one of the most common complications of anesthesia and without prophylactic intervention occurs in about one-third of patients under general anesthesia.
Masoud Entezariasl, Khatereh Isazadehfar, Zahra Noorani   +2 more
doaj  

Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study

Drug, Healthcare and Patient Safety, 2011
Matthew J Hafermann1, Rocsanna Namdar2, Gretchen E Seibold2,3, Robert Lee Page 2nd2,31University of Washington Medical Center, Department of Pharmacy, Seattle, WA; 2University of Colorado Anschutz Medical Campus, School of Pharmacy, Aurora, CO ...
Hafermann MJ, Namdar R, Seibold GE, Page RL 2nd   +3 more
doaj  

Formulation and evaluation of orally disintegrating tablet of ondansetron using natural superdisintegrant [PDF]

, 2015
Introduction: Difficulty in swallowing is common among all age groups, especially elderly and pediatrics. Orally disintegrating tablets may constitute an innovative dosage form that overcome the problem of swallowing and provide a quick onset of action ...
Koosha, Sina., Shahtalebi, Mohammad Ali., Tabbakhian, Majid.   +2 more
core   +1 more source

Erratum to: Ondansetron [PDF]

Drugs, 1993
Anthony Markham, Eugene M. Sorkin
openaire   +2 more sources

Ondansetron does not reduce the shivering threshold in healthy volunteers [PDF]

, 2017
Background. Ondansetron, a serotonin-3 receptor antagonist, reduces postoperative shivering. Drugs that reduce shivering usually impair central thermoregulatory control, and may thus be useful for preventing shivering during induction of therapeutic ...
Bouillon, T., In, J., Komatsu, R., Lauber, R., Orhan-Sungur, M., Podranski, T., Rohrbach, S., Sessler, D.   +7 more
core  

Comparison of the eficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphineinduced pruritus [PDF]

, 2014
Objective: To compare the eficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphine-induced pruritus, in patients at the “Dr.
Cano García, Martha Araceli, Cruz Ferretti, Ulises, Espinosa Galindo, Ana María, Estrada Solís, Yesenia Nohemí, Llanes Garza, Hilda Alicia, López Cabrera, Norma Guadalupe, Palacios Ríos, Dionicio   +6 more
core  

Ondansetron for pediatric gastroenteritis [PDF]

CJEM, 2008
Julie Brahm, Eddy Lang, Christine Meyers
openaire   +3 more sources